v3.26.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jul. 31, 2026
Jul. 29, 2026
Jun. 30, 2026
Jun. 30, 2025
Subsequent Event [Line Items]        
Exercise price per share     $ 94.75  
Net proceeds from issuance of private placement     $ 2,441
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member]        
Subsequent Event [Line Items]        
Gross proceeds from issuance of private placement $ 10,200      
Net proceeds from issuance of private placement 9,200      
Placement agent fees 700      
Other offering expenses $ 300      
Common Stock [Member]        
Subsequent Event [Line Items]        
Number of shares issued       28,235
Common Stock [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member]        
Subsequent Event [Line Items]        
Number of shares issued   167,011    
Pre-funded Warrants [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Exercise price per share $ 0.0001      
Pre-funded Warrants [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member]        
Subsequent Event [Line Items]        
Warrants to purchase of common stock   1,638,835    
Exercise price per share   $ 5.6599    
Series A Warrants [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Maturity date description Series A warrants expire on the earlier of the first anniversary of issuance and 45 days following FDA approval of the Company’s pending premarket approval supplement for LungFit PH II      
Series A Warrants [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member]        
Subsequent Event [Line Items]        
Warrants to purchase of common stock   1,805,846    
Series B Warrants [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Maturity date description Series B warrants expire five years after issuance.      
Series B Warrants [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member]        
Subsequent Event [Line Items]        
Warrants to purchase of common stock   1,805,846    
Series A and Series B Warrants [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Exercise price per share $ 5.51      
Series A and Series B Warrants [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Institutional Investors [Member]        
Subsequent Event [Line Items]        
Exercise price per share   $ 5.66    
Series A and Series B Warrants [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Participating Officers [Member]        
Subsequent Event [Line Items]        
Exercise price per share   $ 5.76    
Warrant [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Number of shares purchased 39,062      
Number of shares purchased, value $ 200